Bibliographic Info
GuidelineMental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders, [3rd ed.].
Year of Publication2023
Issuing InstitutionWorld Health Organization
Recommendation
Status
Updated
Recommended against
Strong
Certainty of evidence
Low
Valproic acid (sodium valproate) should not be used in women and girls of childbearing potential with bipolar disorder in remission owing to the high risk of birth defects and neurodevelopmental disorders in babies in utero